Turkey: Online Sale Of OTC Pharmaceutical Products In Turkey

Online sale of over the counter ("OTC") pharmaceutical products is banned in Turkey because the legislative framework does not specifically address this market segment. Rather, local legislation deems OTC products to be effectively the same as pharmaceuticals, which can only be sold at pharmacies and pharma-organizations.

In general, OTC products are defined as drugs that have been found to be safe and appropriate for use without supervision from a health care professional such as a physician. Therefore, consumers can purchase OTC products without a prescription1. OTC products are used to treat simple diseases which are commonly encountered in daily life. These products are accepted as effective and safe for the disclosed indications2. The global OTC product market, where customers can buy drugs or medicines without a prescription, is steadily increasing in value and volume.

Although the OTC product market is generally increasing across around the world, Turkey has not yet developed a detailed legislative framework. According to the Regulation on the Classification of Human Medicinal Products, pharmaceuticals are classified only as prescription and nonprescription pharmaceuticals. A pharmaceutical is classified as prescription pharmaceutical if it meets any of these criteria (Article 6):

  • Using the pharmaceutical under medical supervision causes direct or indirect danger to health, even if the pharmaceutical is applied correctly,
  • Using the pharmaceutical poses a risk to human health due to frequent and common misuse of the pharmaceutical,
  • With respect to preparing the active substance or formulation, the activity and/or adverse effects need further research,
  • The pharmaceutical is applied via parenteral methods.

If a product is not classified as prescribed, it is deemed to be a nonprescription pharmaceutical. Turkey does not define OTC products, nor regulate requirements for advertisement or specific sale channels. Therefore, under Turkish regulations, nonprescription pharmaceuticals are effectively equivalent to OTC products. As a result, general Turkish regulations regarding pharmaceuticals apply for nonprescription OTC products, including advertising bans. This is a different approach to countries like the United States which have free market conditions for OTC products.

Sale channels for pharmaceuticals are addressed by the Law on Pharmaceuticals and Medical Preparations, which states that regardless of whether a pharmaceutical is prescription or nonprescription, it can only be sold at pharmacies and pharma-organizations (such as pharmaceutical warehouses) (Article 1). Therefore, OTC products are deemed to be nonprescription pharmaceuticals in Turkey, which can only be sold at pharmacies.

Turkish legislation prohibits the sale of pharmaceuticals via the internet or any other electronic medium (Article 24 of the Law on Pharmacists and Pharmacies), even to the extent that pharmacists cannot have websites. Therefore, OTC products cannot be sold online in Turkey.

The restrictions may be considered lucky, considering Turkish society's tendency to use and misunderstand pharmaceuticals. According to research, many Turkish patients do not know the difference between a virus and a bacteria, believing that antibiotics treats diseases caused by either of these infections. The same research showed that 36% of patients believe antibiotics reduce a fever and lower pain, tiredness and lethargy3.

The downsides of using nonprescription pharmaceuticals, which may increase through online sale of OTC products, include:

  • Patients fail to receive the pharmaceutical's intended result and benefit due to misuse.
  • Increased risk of adverse effects and interaction with other pharmaceuticals.
  • Increased treatment costs and waste of resources.
  • Reduced records of pharmacovigilance.

The number of the crimes committed through the internet increases daily. Counterfeit pharmaceuticals are a growing and profitable business for fraudsters. Generic top level domains can be registered by anybody, including .com, .net, .biz, .org and .info. Therefore, it is not always possible to know who is behind any given domain. Fraudsters can also activate websites cheaply and continue to sell fake pharmaceutical products, even if access is banned to their main website. As a result, although many legislative prohibitions and restrictions exist, fraudsters can easily take advantages of freedom and anonymity available online, using the internet as a tool to commit crimes.

Patients are most likely to buy weight loss medications and aphrodisiacs online. In March 2016, 500 kilograms of fake weight loss medications were seized in an operation organized the by Anti-Smuggling Department of the Istanbul Police. Despite the seizures, it was reported that a large number of the fake weight loss medications had already been sold online before the raid.

From an intellectual property point of view, online sale of OTC pharmaceuticals may pave the way for counterfeit products. Websites are not as easily inspected as physical pharmacies are. The issue is so widespread that the United States' Food and Drug Administration published an announcement warning patients about the dangers of buying pharmaceuticals online (including the risk of counterfeit products), as well as ways consumers can avoid or reduce these risks4.

The Turkish pharmaceutical market is criticized for its prohibition on advertising OTC products. Arguably, advertisements could be used to inform society and promote awareness about using OTC products.

Critics argue that online sale of OTC products would enable better access to pharmaceuticals, as well as increase competition, thus lowering pharmaceutical prices. However, since there is no efficient legal way to control online pharmaceutical sales (including OTC products), the Turkish pharma market is not ready for adopting online sale of OTC products yet.

Unlike other countries in the European Union and the United States, Turkey does not specifically regulate OTC products. Therefore, these products are subject to the same prohibitions and obligations as any other pharmaceutical. Since the Turkish OTC product market remains unregulated, the issue of whether local consumers are ready to access pharmaceuticals without pharmacist guidance remain debatable.


1. http://www.fda.gov/AboutFDA/Transparency/Basics/ucm194951.htm

2. Turkish Pharmacist Association R&D Unit Report – Non-Prescription Pharmaceuticals and Non-Pharmaceutical Products: Definition and Intervention

3. Turkish Pharmacist Association R&D Unit Report – Non-Prescription Pharmaceuticals and Non-Pharmaceutical Products: Definition and Intervention

4. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048396.htm

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Merve Altınay
Similar Articles
Relevancy Powered by MondaqAI
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions